Silicasomes in Oncology: From Conventional Chemotherapy to Combined Immunotherapy
Molecules · 2025
DOI: 10.3390/molecules30061257 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, 2025. Verfasst von Alicia Arroyo-Nogales und 4 weiteren Autor:innen. Beteiligte Einrichtung: Materials and Aerospace Production Department, Superior Technic School of Aeronautics and Space Engineering, Politechnic University of Madrid Departm…. Hauptthemen laut MEDLINE: Immunotherapy, Silicon Dioxide, Neoplasms, Nanoparticles. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 113 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: UE.
Themen: Onkologische Pflege
Abstract (Originalsprache)
The use of nanoparticles as drug carriers in oncology has evolved from their traditional role as chemotherapy carriers to their application in immunotherapy, exploiting not only their passive accumulation in solid tumors but also their ability to interact with immune cells. Silicasomes are highly versatile nanoplatforms composed of a mesoporous silica core whose external surface is coated with a lipid bilayer that allows the co-delivery of therapeutic agents having different chemical natures (small molecules, proteins, enzymes, or oligonucleotides, among others). Herein, cutting-edge advances carried out in the development and application of silicasomes are presented, providing a general description of the performance of these nanotransporters. Additionally, the specific load of chemotherapeutic drugs is explored, followed by a discussion of the immunotherapeutic application of silicasomes and the combination of different therapeutic strategies, including theragnosis, in a single silicasome platform, highlighting the enormous potential of these nanosystems.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Materials and Aerospace Production Department, Superior Technic School of Aeronautics and Space Engineering, Politechnic University of Madrid Department Materiales y Producción Aeroespacial, ETSI Aeronáutica y del Espac…
ORCID-Profile: Guillermo Plaza-Palomo, Javier González-Larre, Alejandro Baeza
Förderung
- UE
Zitieren
APA
Arroyo-Nogales, A., Plaza-Palomo, G., González-Larre, J., Jiménez-Falcao, S., & Baeza, A. (2025). Silicasomes in Oncology: From Conventional Chemotherapy to Combined Immunotherapy. Molecules. https://doi.org/10.3390/molecules30061257
Vancouver
Arroyo-Nogales A, Plaza-Palomo G, González-Larre J, Jiménez-Falcao S, Baeza A. Silicasomes in Oncology: From Conventional Chemotherapy to Combined Immunotherapy. Molecules. 2025. doi:10.3390/molecules30061257
BibTeX
@article{ArroyoNogales2025,
author = {Arroyo-Nogales, Alicia and Plaza-Palomo, Guillermo and González-Larre, Javier and Jiménez-Falcao, Sandra and Baeza, Alejandro},
title = {Silicasomes in Oncology: From Conventional Chemotherapy to Combined Immunotherapy},
journal = {Molecules},
year = {2025},
doi = {10.3390/molecules30061257}
}
EUVIMED